Axxiem Web Solutions’ Post

Leveraging robust #GenAI and #LLM technologies powered by LifeSphere NavaX, we have built the most comprehensive and innovative Regulatory platform in Life Sciences. 💡 Discover how LifeSphere Regulatory can add value to your organization and unlock more than 50% efficiency gains by downloading the fact sheet now: https://lnkd.in/e5KkS6qK #regulatoryoperations #regulatory #lifesciences #biotech #pharmatech

👀 Here's an eye-opening juxtaposition of large-molecule therapeutic engineering. 🚧 I just wrapped a #businessofbiotech podcast recording with Skye Bioscience Inc. leader Punit Dhillon. Among other things, we discussed the inherent advantage of the company's CB 1-targeting antibody in obesity. Namely, because it's a large molecule, it can't cross the blood-brain barrier and thus, isn't likely to incite the CNS-related side effects we've seen in so many small molecule obesity drugs. 🔓 On the other hand, we have this fresh Bioprocess Online column from Tyler Menichiello featuring Aliada Therapeutics CSO John Dunlop. He explains why his company is engineering an end-around approach to getting large molecules INTO the CNS, BY WAY OF the blood-brain barrier. This, he says, could change the standard (and unpleasant) intrathecal bolus injection approach to getting #biologics to the brain for CNS disorders. Sometimes nature's rules enable favorable outcomes. Other times, we have to bend those rules to create favorable outcomes.

Adopt a “Designed for IRT” mindset when developing your next protocol. #clinicaltrials #biotech #IRTInsights #clinicalresearch

One of our biggest research questions is periodicity – that is, how often and over what period of time, is #celltherapy with the proprietary investigational product we study (HB-adMSCs) most effective? Listen in to clinicians David and Sherry, then catch the full episode at https://lnkd.in/gKSE5-Qi #biotech #research #hope

After a deep-dive survey focused on innovation readiness in #biotech, Parexel brought experts together to discuss some of these findings. Watch this on-demand webinar on how adaptive strategies can bring more efficient, patient-friendly trials. https://bit.ly/3NJ2xxE

In the latest Bio Banter episode, Michael Margolis, RPh., and Daniel Parisotto, Ph.D., discuss the fascinating world of private biotech markets. Do they see continued strength or decline? On the one hand, deal-making activities declined from the zeal of the pandemic highs, but things still look good compared to pre-pandemic metrics… Curious for more? Tune in today. https://bit.ly/48pEbkq #Therapeutics #Biotech #LetsTalkFuture #ThePowerofOppenheimerThinking

LAL endotoxin testing is simple and fast. It's a gel clot test, meaning that when you drop your sample into a sample tube with the reagent, it'll clot if there's contamination. This is a very speedy and easy to interpret test: imagine the industries that are going to benefit when this technology becomes accessible to them with our recombinantly generated endotoxin assay! #biotechnology #lifescience #lifesciences #biomedicalscience #technology #technews #newtech #latesttech #latesttechnews #futuretech #innovation #techindustry #tech #biotech #savethecrabs

Welcome to the first "REIDing the Market" video. The post is meant to capture my monthly insights I have experienced in the biotech field and create avenues of discussion. Please feel free to send me suggestions or post comments for future insights 😊 #swordbio #reidingthemarket #biotech

Having standards for your IRT approach is very powerful. However, it is crucial to continue evolving and refining them; otherwise, they may become bloated. #clinicaltrials #clinicalresearch #biotech

Explore the latest release of New Stock Compounds 2024! Dive into Molport collection of newly added commercially available compounds designed to accelerate your scientific discovery and innovation. Follow the link to access downloadable files:    https://lnkd.in/dcwf-_ZX    #NewCompounds #ScientificInnovation #DrugDiscovery #ResearchAndDevelopment #Biotechnology #ChemistryUpdates #Molport